RESUMO
Neuropathic pain is a worldwide health problem with no consensus regarding its optimal therapy. This study compared the analgesic effect and gastric, hepatic, and renal safety of combined low doses of diclofenac and celecoxib with gabapentin versus their individual high doses in the treatment of neuropathic pain in rats. Left sciatic nerve ligation was used as neuropathic pain model. Rats were allocated into 7 groups (7 rats for each): sham control; model group (received vehicle); Gaba-group (received gabapentin (100â¯mg/kg /day); Diclo 10-group (received diclofenac (10â¯mg/kg); Cele 10-group (received celecoxib (10â¯mg/kg/day); Gabaâ¯+â¯Diclo 5 (receivedgabapentin(100â¯mg/kg /day) plus diclofenac (5â¯mg/kg); Gabaâ¯+â¯Cele 5 (received gabapentin (100â¯mg/kg/day) plus celecoxib (5â¯mg/kg)). The analgesic effect was assessed using both hot plate and acetone tests. The impact of the used drugs on peptic ulcer index, liver enzymes, and serum urea and creatinine was evaluated, along with histopathological examination and oxidative stress parameters. Combination therapy of low dose of either diclofenac or celecoxib, with gabapentin showed higher analgesic effect compared with their individual high doses as indicated by prolonged response time in hot plate test and decreased frequency of paw withdrawal in acetone test. Their effect was associated with gentle effect on gastric mucosa, renal and hepatic integrity and oxidative stress parameters. In conclusion, the use of combined low doses of either diclofenac or celecoxib with gabapentin is better than high dose monotherapy regarding both the efficacy and safety.
Assuntos
Aminas/uso terapêutico , Analgésicos/uso terapêutico , Celecoxib/uso terapêutico , Ácidos Cicloexanocarboxílicos/uso terapêutico , Diclofenaco/uso terapêutico , Neuralgia/tratamento farmacológico , Ácido gama-Aminobutírico/uso terapêutico , Aminas/administração & dosagem , Aminas/efeitos adversos , Analgésicos/administração & dosagem , Analgésicos/efeitos adversos , Animais , Comportamento Animal/efeitos dos fármacos , Celecoxib/administração & dosagem , Celecoxib/efeitos adversos , Ácidos Cicloexanocarboxílicos/administração & dosagem , Ácidos Cicloexanocarboxílicos/efeitos adversos , Diclofenaco/administração & dosagem , Diclofenaco/efeitos adversos , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Quimioterapia Combinada , Gabapentina , Masculino , Estresse Oxidativo/efeitos dos fármacos , Medição da Dor , Limiar da Dor , Ratos Wistar , Resultado do Tratamento , Ácido gama-Aminobutírico/administração & dosagem , Ácido gama-Aminobutírico/efeitos adversosRESUMO
Aging is associated with reduced hippocampal neurogenesis, which may in turn contribute to cognitive impairment. We assessed the effect of Ginkgo biloba (Gb) on hippocampal neurogenesis in elderly male mice using immunohistochemistry. We used anti-caspase-3 as a marker of apoptosis, anti-GFAP as a marker of neural stem cells, anti-Ki-67 as a specific marker for cellular proliferation and anti-doublecortin (DCX) to detect newly born neurons in the hippocampal dentate gyrus (DG) of aged male mice. The 24-month-old male mice were divided into two groups: a control group treated with distilled water and a group fed with Gb at a dose of 100 mg/kg once daily for 28 days. A sharp decrease in apoptotic cells in Gb-treated compared to nontreated mice was observed by anti-csapase-3 immunostaining. A large number of GFAP+ve cells was found in the subgranular zone of the DG of Gb-treated mice, suggesting an increase in the pool of neural stem cells by Gb treatment. There was also an increase in Ki-67 immunoreactive cells, indicating increased cell proliferation in the DG in the Gb-treated compared to nontreated group. A significant increase in newborn DCX+ve neurons with well-developed tertiary dendrites was also found in the Gb-treated compared to nontreated group. Using Western blot analysis, the expression of DCX protein in the Gb group was also significantly increased compared to the control. The results support a beneficial role of Gb on hippocampal neurogenesis in the context of brain aging.